Vivifrail Exercise Program in Nonagenarians: Effects on Function, Muscle, and Cognition
Vivifrail
Effects of a Multicomponent Exercise Program Based on the Vivifrail Protocol on Functional Capacity, Muscle Morphology, and Cognition in Nonagenarians: A Randomized Clinical Trial
2 other identifiers
interventional
54
1 country
2
Brief Summary
This randomized clinical trial investigates the effects of a home-based multicomponent exercise program (Vivifrail) on physical function, muscle morphology, and cognition in community-dwelling adults aged 90 years and older. Participants are randomized into three groups: Vivifrail at least twice a week, Vivifrail at least three times a week, or a control group. Outcomes are assessed at baseline, 12 weeks, and 24 weeks. The primary outcome is physical function measured by the Short Physical Performance Battery (SPPB).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2026
CompletedFirst Submitted
Initial submission to the registry
July 20, 2026
CompletedFirst Posted
Study publicly available on registry
July 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
July 28, 2026
July 1, 2026
1.2 years
July 20, 2026
July 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in physical function measured by the Short Physical Performance Battery (SPPB) total score
Total SPPB score ranging from 0 to 12 points (higher scores indicate better lower-extremity physical function), combining balance, gait speed, and chair-stand tests.
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
Secondary Outcomes (10)
Mobility - Timed Up and Go (TUG)
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
Mobility under dual task - Cognitive TUG and dual-task cost (DTC%) ·
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
Handgrip strength
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
Lower-limb muscle power - Five-times sit-to-stand
Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
Gait speed
aseline (T0), 12 weeks (T1), and 24 weeks (T2)).
- +5 more secondary outcomes
Study Arms (3)
Vivifrail - 2 sessions/week (G1)
EXPERIMENTALHome-based Vivifrail multicomponent exercise program performed at least twice a week for 24 weeks, individualized by functional profile (SPPB and Vivifrail passport).
Vivifrail - 3 sessions/week (G2)
EXPERIMENTALHome-based Vivifrail multicomponent exercise program performed at least three times a week for 24 weeks, individualized by functional profile.
Control (GC)
NO INTERVENTIONParticipants maintain usual activities without a structured exercise program during the 24-week period.
Interventions
Individualized multicomponent home-based training (strength/power, balance, gait, and flexibility) prescribed according to the participant's Vivifrail functional profile.
Eligibility Criteria
You may qualify if:
- Aged 90 years or older
- Living in the community (own or family home)
- Able to walk independently or with a walking aid (cane or walker), without third-party assistance
- Minimum cognitive capacity to understand and perform the exercises (MMSE, education-adjusted cutoffs)
- Adequate home conditions to perform the program
- Availability of a family member or caregiver to support the sessions
- Signed informed consent (with legal guardian assistance when needed)
You may not qualify if:
- \- Total inability to walk or permanent bedridden condition
- Severe cognitive impairment preventing safe understanding and execution of exercises
- Severe orthopedic, neurological, or rheumatological conditions preventing exercise
- Concurrent participation in another structured exercise program
- Anticipated unavailability (relocation, planned hospitalization, or institutionalization) during the intervention
- Refusal to sign informed consent or absence of a legal guardian when required
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hospital de Clínicas de Porto Alegre (HCPA) - Geriatrics outpatient clinic
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
Escola de Educação Física, Fisioterapia e Dança (ESEFID/UFRGS) - and participants' homes
Porto Alegre, Rio Grande do Sul, 90690-200, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors are blinded to group allocation. Participants and interventionists cannot be blinded due to the autonomous, home-based nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoral Candidate and Principal Investigator
Study Record Dates
First Submitted
July 20, 2026
First Posted
July 28, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
July 28, 2026
Record last verified: 2026-07